← Back to Analyst Consensus 
CGON Buy
CG Oncology, Inc.
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 7, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| May 19, 2026 | Wolfe Research | initiate | — → Peer Perform | — | 54% |
| May 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 14, 2026 | Truist Securities | reiterate | Buy → Buy | — | 54% |
| May 11, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 11, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 11, 2026 | Truist Securities | reiterate | Buy → Buy | — | 54% |
| May 11, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Apr 27, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Apr 17, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Apr 7, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $80 | 44% |
| Feb 10, 2026 | Truist Securities | maintain | Buy → Buy | $75 | 54% |
| Jan 21, 2026 | RBC Capital | maintain | Outperform → Outperform | $73 | 55% |
| Jan 16, 2026 | Piper Sandler | maintain | Overweight → Overweight | $70 | 54% |
| Jan 12, 2026 | Truist Securities | maintain | Buy → Buy | $66 | 54% |
| Dec 11, 2025 | Wedbush | initiate | — → Outperform | $70 | 58% |
| Nov 24, 2025 | Truist Securities | initiate | — → Buy | $62 | 54% |
| Nov 17, 2025 | RBC Capital | maintain | Outperform → Outperform | $61 | 55% |
| Oct 8, 2025 | Guggenheim | initiate | — → Buy | $90 | 52% |
| Sep 26, 2025 | JP Morgan | maintain | Overweight → Overweight | $47 | 55% |
| Sep 17, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $79 | 54% |
| Sep 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Sep 8, 2025 | Jones Trading | initiate | — → Buy | $50 | 50% |
| Sep 8, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $75 | 50% |
| Sep 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Sep 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Aug 19, 2025 | Piper Sandler | initiate | — → Overweight | $55 | 54% |
| Jul 16, 2025 | RBC Capital | maintain | Outperform → Outperform | $53 | 55% |
| Jun 17, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $56 | 54% |
| May 19, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $52 | 54% |
| May 2, 2025 | JP Morgan | initiate | — → Overweight | $41 | 55% |
| Apr 29, 2025 | RBC Capital | maintain | Outperform → Outperform | $68 | 55% |
| Apr 28, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $75 | 50% |
| Apr 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Apr 16, 2025 | Scotiabank | initiate | — → Sector Perform | $23 | 55% |
| Mar 31, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Mar 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Jan 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Jan 7, 2025 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Dec 6, 2024 | RBC Capital | reiterate | Outperform → Outperform | $66 | 55% |
| Dec 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Nov 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $75 | 44% |
| Oct 24, 2024 | UBS | initiate | — → Buy | $60 | 54% |
| Oct 8, 2024 | B of A Securities | maintain | Buy → Buy | $65 | 53% |
| Sep 23, 2024 | RBC Capital | initiate | — → Outperform | $66 | 55% |
Price Target Trend
Jul 15, 2026 Latest: $91.08 Oct 25, 2026
EPS Estimates
+1q $-0.84
Lo: $-1.03 Hi: $-0.67
12 analysts 0q $-0.81
Lo: $-0.96 Hi: $-0.66
12 analysts +1y $-3.02
Lo: $-3.63 Hi: $-2.15
12 analysts 0y $-3.23
Lo: $-3.60 Hi: $-2.79
12 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days